We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Enzyme Corrects Human Gene Mutations

By Biotechdaily staff writers
Posted on 08 Aug 2002
Researchers in Wales and Scotland, who discovered a gene repair mechanism called MBD4 earlier, have since found that gene mutations are up to three times more common in mice lacking the MBD4 enzyme. More...
The findings were reported in the July 19, 2002, issue of Science.

The practice of shutting down genes by marking them with chemical switches called methyl groups greatly increases the chances of mutation. One out of every three genetic changes that cause disease can be attributed to methyl-groups. The researchers have discovered that the MBD4 enzyme tries to repair the damage caused by methyl-groups before the damage can do harm. They say the enzyme may play an important role in reducing the susceptibility to diseases such as hemophilia, cystic fibrosis, and cancer.

"Humans are complicated chemical machines, and we have evolved to use certain chemical tricks to control gene expression, and these unfortunately have a significant downside in terms of gene damage,” said Prof. Alan Clarke, of the School of Biosciences at Cardiff University (UK; www.cf.ac.uk). "As humans, we therefore had to invent a tool kit to repair the damage, and what we show here is that loss of part of that tool kit can increase the risk of developing cancer.” Prof. Clarke led the study, along with Prof. Adrian Bird of the University of Edinburgh (UK; www.ed.ac.uk).




Related Links:
Cardiff Univ
Univ. of Edinburgh

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Thyroid Test
Anti-Thyroid EIA Test
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.